BrainMapp Software Solutions has been established as a new spin-off company emerging from the Autonomous University of Barcelona (UAB) and the Computer Vision Center (CVC), bringing a specialised digital technology to the medical imaging sector. The company’s core offering targets a critical need in neurosurgery: providing surgeons with enhanced brain mapping capabilities and improved identification of critical zones during tumour removal procedures.
The technology represents a direct commercialisation effort of research developed within the university and research institution environment. Rather than remaining confined to academic settings, the innovation is now being packaged as a software solution intended for deployment in clinical settings across Europe and beyond.
Addressing a surgical challenge
Brain tumour surgery presents one of neurosurgery’s most demanding challenges. Surgeons must balance the competing imperatives of removing diseased tissue while preserving healthy brain function and avoiding damage to critical neurological zones. The margin for error is minimal, and intraoperative guidance systems have become increasingly important in modern surgical practice.
BrainMapp’s solution seeks to enhance the surgical team’s ability to visualise and map brain structures in real-time, providing information that can inform decision-making during complex procedures. The technology draws on computer vision expertise developed at the CVC, one of Spain’s leading research institutions in this field.
Barcelona’s healthtech ecosystem
The emergence of BrainMapp reflects the growing maturity of Spain’s healthtech sector, particularly within Barcelona’s innovation ecosystem. The city has established itself as a notable hub for medical technology development, supported by strong university research institutions and clinical partners capable of validating new technologies.
The partnership between UAB and CVC in creating this spin-off demonstrates a model increasingly common in European innovation: leveraging institutional research capacity to create commercially viable healthcare solutions. Universities and research centres across Europe are increasingly formalising mechanisms to move promising technologies from laboratory to market.
Medical imaging and surgical assistance technologies remain priority areas for European healthtech investment, reflecting both clinical demand and regulatory pathways that have matured considerably over the past decade. Solutions that enhance surgical precision without requiring wholesale changes to existing surgical workflows hold particular appeal to hospital systems navigating technology adoption.
The establishment of BrainMapp adds to the growing portfolio of European companies developing AI and computer vision applications for medical use cases. As regulatory frameworks around software-as-a-medical-device continue to evolve across EU member states, spin-offs from established research institutions increasingly have the infrastructure and credibility to navigate these requirements effectively.